IL33 and non-small cell lung carcinoma: Infection with the gram-negative E.Coli has been associated with tumor growth, progression and metastasis of non-small cell lung cancer, by promoting lipid synthesis through the TLR4/9 pathway and, also, by facilitating cancer stem cell properties through the TLR4/IL-33 pathway [51,52,53,54].